India steps up efforts to battle rising tide of diabetes 24 May 2012
Boehringer flags up Phase II tiotropium results in asthma as prelude to Phase III reveal 24 May 2012
Eisai wins Swedish reimbursement for epilepsy drug after two year court case 24 May 2012
Intercell plugs financing gap to sustainability with €35 million 24 May 2012
Bayer submits US, European applications for regorafenib in mCRC 24 May 2012
IMI launches €224m R&D programme to tackle antibiotic resistance 24 May 2012
Phase III maintenance data support Shire's EU Venvanse filing 24 May 2012
Chinese public research meets private enterprise as CASiGEN acquires diabetes candidates 24 May 2012
UK generics industry: "Let's shut the stable door before the horse bolts" 24 May 2012
Health Canada accepts Seattle Genetics' new drug submission for Adcetris 24 May 2012
Chinese firm acquires selected Asian rights to Kinex's oncology candidate 24 May 2012
Talks start on international convention delinking R&D costs from prices 24 May 2012
Senate successfully trims amendment count before PDUFA vote; clock set 24 May 2012
Kyowa Kirin's mogamulizumab priced in Japan and set for first launch 24 May 2012
Celldex's CDX-011 EMERGEs as advantageous targeted option in advanced breast cancer 24 May 2012
